<--- Back to Details
First PageDocument Content
Health / Chugai Pharmaceutical Co. / Ibandronic acid / Anatomy / Taisho Pharmaceutical Co. / Bone density / Medicine / Bisphosphonates / Osteopathies / Osteoporosis
Date: 2015-02-10 01:01:03
Health
Chugai Pharmaceutical Co.
Ibandronic acid
Anatomy
Taisho Pharmaceutical Co.
Bone density
Medicine
Bisphosphonates
Osteopathies
Osteoporosis

Translation Taisho Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. New Drug Application Filed for Ibandronate Sodium Hydrate Oral Agent, Bisphosphonate Antiresorptive Agent

Add to Reading List

Source URL: www.taisho.co.jp

Download Document from Source Website

File Size: 16,35 KB

Share Document on Facebook

Similar Documents

Master’s Thesis Proposal  The Effect of Dose Reduction on Bone Mineral Density and Strength assessed via Computed Tomography Background Osteoporotic vertebral fractures constitute a health threat with tremendous costs

Master’s Thesis Proposal The Effect of Dose Reduction on Bone Mineral Density and Strength assessed via Computed Tomography Background Osteoporotic vertebral fractures constitute a health threat with tremendous costs

DocID: 1uLoC - View Document

Articles  © 2017 Nature America, Inc., part of Springer Nature. All rights reserved. Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in

Articles © 2017 Nature America, Inc., part of Springer Nature. All rights reserved. Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in

DocID: 1uxOe - View Document

67 Reduced Changes In Bone Mineral Density In CHB Patients Receiving Tenofovir Alfenamide (TAF) Compared With Tenofovir disoproxil fumarate Wai-Kay Seto2, Yasuhiro Asahina3, Cheng-Yuan Peng4, Carol Stanciu5, Djamal Abdur

67 Reduced Changes In Bone Mineral Density In CHB Patients Receiving Tenofovir Alfenamide (TAF) Compared With Tenofovir disoproxil fumarate Wai-Kay Seto2, Yasuhiro Asahina3, Cheng-Yuan Peng4, Carol Stanciu5, Djamal Abdur

DocID: 1timf - View Document

Specialised Biochemical Testing Osteoporosis Diagnosis: Prevention of the Silent Disease Osteoporosis is a disease of bones that leads to an increased risk of fracture. In osteoporosis, the bone mineral density (BMD) is

Specialised Biochemical Testing Osteoporosis Diagnosis: Prevention of the Silent Disease Osteoporosis is a disease of bones that leads to an increased risk of fracture. In osteoporosis, the bone mineral density (BMD) is

DocID: 1si7o - View Document

Bo n e an d m in eral Prevalence  10

Bo n e an d m in eral Prevalence 10

DocID: 1r6Qq - View Document